INR 580.45
(1.84%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 985.34 Million INR | -4.47% |
2022 | 1.03 Billion INR | 24.31% |
2021 | 829.72 Million INR | 15.81% |
2020 | 716.42 Million INR | 48.75% |
2019 | 481.63 Million INR | 0.94% |
2018 | 477.12 Million INR | 12.81% |
2017 | 422.93 Million INR | 4.82% |
2016 | 403.5 Million INR | 17.51% |
2015 | 343.36 Million INR | 11.17% |
2014 | 308.86 Million INR | 3.36% |
2013 | 298.81 Million INR | 11.84% |
2012 | 267.17 Million INR | 15.41% |
2011 | 231.51 Million INR | -33.45% |
2010 | 347.89 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 294.53 Million INR | 25.07% |
2023 Q4 | 235.49 Million INR | -47.78% |
2023 Q1 | 393.69 Million INR | 29.6% |
2023 FY | 985.34 Million INR | -4.47% |
2023 Q2 | 440.66 Million INR | 11.93% |
2023 Q3 | 450.99 Million INR | 2.35% |
2022 Q3 | 241.34 Million INR | -42.64% |
2022 Q4 | 303.78 Million INR | 25.87% |
2022 FY | 1.03 Billion INR | 24.31% |
2022 Q2 | 420.73 Million INR | 1.27% |
2022 Q1 | 415.45 Million INR | 131.9% |
2021 Q1 | 218.04 Million INR | 52.55% |
2021 Q3 | 216.24 Million INR | 17.73% |
2021 FY | 829.72 Million INR | 15.81% |
2021 Q4 | 179.15 Million INR | -17.15% |
2021 Q2 | 183.67 Million INR | -15.76% |
2020 Q2 | 221.48 Million INR | 22.2% |
2020 FY | 716.42 Million INR | 48.75% |
2020 Q3 | 170.75 Million INR | -22.91% |
2020 Q4 | 142.93 Million INR | -16.29% |
2020 Q1 | 181.25 Million INR | 43.26% |
2019 Q3 | 131.85 Million INR | -4.71% |
2019 Q1 | 127.36 Million INR | 22.34% |
2019 FY | 481.63 Million INR | 0.94% |
2019 Q4 | 126.51 Million INR | -4.05% |
2019 Q2 | 138.37 Million INR | 8.64% |
2018 Q1 | 289.79 Million INR | 173.56% |
2018 Q4 | 104.11 Million INR | 0.0% |
2018 FY | 477.12 Million INR | 12.81% |
2018 Q3 | 104.11 Million INR | -26.41% |
2018 Q2 | 141.47 Million INR | -51.18% |
2017 FY | 422.93 Million INR | 4.82% |
2017 Q2 | 96.09 Million INR | 0.0% |
2017 Q1 | 96.09 Million INR | 7.64% |
2017 Q4 | 105.93 Million INR | 0.0% |
2017 Q3 | 105.93 Million INR | 10.24% |
2016 Q4 | 89.27 Million INR | 0.0% |
2016 FY | 403.5 Million INR | 17.51% |
2016 Q2 | 96.58 Million INR | 0.0% |
2016 Q1 | 96.58 Million INR | 12.63% |
2016 Q3 | 89.27 Million INR | -7.56% |
2015 Q1 | 96.15 Million INR | 0.0% |
2015 Q2 | 96.15 Million INR | 0.0% |
2015 Q3 | -833.23 Million INR | -966.54% |
2015 Q4 | 85.75 Million INR | 110.29% |
2015 FY | 343.36 Million INR | 11.17% |
2014 FY | 308.86 Million INR | 3.36% |
2013 FY | 298.81 Million INR | 11.84% |
2012 FY | 267.17 Million INR | 15.41% |
2011 FY | 231.51 Million INR | -33.45% |
2010 FY | 347.89 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 15.86 Billion INR | 93.791% |
Aurobindo Pharma Limited | 39.23 Billion INR | 97.489% |
Glenmark Life Sciences Limited | 11.64 Billion INR | 91.535% |
Granules India Limited | 7.18 Billion INR | 86.281% |
Indoco Remedies Limited | 4.74 Billion INR | 79.251% |
Achyut Healthcare Limited | 1.6 Million INR | -61139.59% |
Ajanta Pharma Limited | 30.46 Billion INR | 96.765% |
Alkem Laboratories Limited | 32.83 Billion INR | 96.999% |
Alpa Laboratories Limited | 156.14 Million INR | -531.037% |
Brooks Laboratories Limited | 51.18 Million INR | -1825.254% |
AstraZeneca Pharma India Limited | 2.6 Billion INR | 62.108% |
Bliss GVS Pharma Limited | 1.41 Billion INR | 30.571% |
Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 98.972% |
Eris Lifesciences Limited | 4.94 Billion INR | 80.066% |
FDC Limited | 5.34 Billion INR | 81.577% |
Glenmark Pharmaceuticals Limited | 67.56 Billion INR | 98.542% |
Gufic Biosciences Limited | 1.07 Billion INR | 8.571% |
Ind-Swift Laboratories Limited | 2.12 Billion INR | 53.613% |
Ipca Laboratories Limited | 13.91 Billion INR | 92.919% |
Jagsonpal Pharmaceuticals Limited | 773.41 Million INR | -27.403% |
Krebs Biochemicals & Industries Limited | 46.15 Million INR | -2034.815% |
Lasa Supergenerics Limited | 291.17 Million INR | -238.404% |
Laurus Labs Limited | 3.01 Billion INR | 67.273% |
Lupin Limited | 95.67 Billion INR | 98.97% |
Mankind Pharma Limited | 23.15 Billion INR | 95.744% |
Medicamen Biotech Limited | 335.16 Million INR | -193.986% |
Medico Remedies Limited | 161.84 Million INR | -508.824% |
Megasoft Limited | 49.52 Million INR | -1889.471% |
NATCO Pharma Limited | 10.05 Billion INR | 90.203% |
Piramal Pharma Limited | 19.91 Billion INR | 95.052% |
RPG Life Sciences Limited | 1.63 Billion INR | 39.753% |
Sigachi Industries Limited | 579.88 Million INR | -69.92% |
Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 99.361% |
Suven Pharmaceuticals Limited | 1.4 Billion INR | 29.758% |
Syncom Formulations (India) Limited | 942.39 Million INR | -4.557% |
Unichem Laboratories Limited | 6.72 Billion INR | 85.35% |
Wanbury Limited | 1.16 Billion INR | 15.124% |
Windlas Biotech Limited | 1 Billion INR | 2.103% |
ZIM Laboratories Limited | 1.01 Billion INR | 2.736% |
Zydus Lifesciences Limited | 43.17 Billion INR | 97.718% |
Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 67.975% |
Divi's Laboratories Limited | 14.17 Billion INR | 93.046% |
Hester Biosciences Limited | 908.84 Million INR | -8.418% |
Procter & Gamble Health Limited | 2.99 Billion INR | 67.105% |
Amrutanjan Health Care Limited | 1.09 Billion INR | 10.341% |
Bal Pharma Limited | 389.89 Million INR | -152.724% |
Strides Pharma Science Limited | 9.16 Billion INR | 89.246% |
Venus Remedies Limited | 1.91 Billion INR | 48.58% |
Aarti Pharmalabs Limited | 3.07 Billion INR | 67.95% |
Nectar Lifesciences Limited | 625.55 Million INR | -57.517% |
Shilpa Medicare Limited | 2.18 Billion INR | 54.813% |
Aarti Drugs Limited | 1.16 Billion INR | 15.601% |
IOL Chemicals and Pharmaceuticals Limited | 1.09 Billion INR | 10.325% |
Suven Life Sciences Limited | 109.75 Million INR | -797.809% |
Ind-Swift Limited | 946.56 Million INR | -4.097% |
Valiant Laboratories Limited | 36.28 Million INR | -2615.272% |
J. B. Chemicals & Pharmaceuticals Limited | 8.41 Billion INR | 88.294% |
Solara Active Pharma Sciences Limited | 4.57 Billion INR | 78.485% |
Themis Medicare Limited | 782.85 Million INR | -25.866% |
Hikal Limited | 2.48 Billion INR | 60.37% |
Torrent Pharmaceuticals Limited | 21.42 Billion INR | 95.4% |
Sequent Scientific Limited | 2.9 Billion INR | 66.044% |
Novartis India Limited | 470.1 Million INR | -109.603% |
Wockhardt Limited | 6.4 Billion INR | 84.604% |
Jubilant Pharmova Limited | 14.45 Billion INR | 93.183% |
Biofil Chemicals and Pharmaceuticals Limited | 16.2 Million INR | -5978.737% |
Neuland Laboratories Limited | 2.92 Billion INR | 66.368% |
Morepen Laboratories Limited | 1.98 Billion INR | 50.422% |
Kilitch Drugs (India) Limited | 412.42 Million INR | -138.914% |
Mangalam Drugs & Organics Limited | 676.14 Million INR | -45.729% |